Product Information

LISDEXAMFETAMINE 30 MG TB CHEW is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.0527 per EA under NDC 00480973901. Its NADAC has been published 88 times since Oct 23, 2024.

LISDEXAMFETAMINE 30 MG TB CHEW

lisdexamfetamine dimesylate
$4.0527per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00480973901

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215415

On Market Since

9/16/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has been published 88 times since Oct 23, 2024, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.

Current price$4.0527 per EA
All-time high$8.1813 (Nov 13, 2024)
All-time low$4.0527 (Jun 17, 2026)
52-week high$7.3210
52-week low$4.0527
Median price$6.9861
Average price$6.6861
Largest weekly change-15.7% (Nov 20, 2024)
Weeks tracked88
Tracking sinceOct 23, 2024

Price History

1W

0.0%

1M

-5.5%

3M

-19.4%

6M

-36.2%

1Y

-41.9%

3Y

N/A

5Y

N/A

All

-50.5%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 30 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG TB CHEW, manufactured by Teva Pharmaceuticals USA Inc., is $4.0527 per EA (NDC 00480973901), effective Jun 24, 2026.

How has the price of LISDEXAMFETAMINE 30 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has declined 50.5%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG TB CHEW?

Since Oct 23, 2024, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has ranged from a low of $4.0527 (Jun 17, 2026) to a high of $8.1813 (Nov 13, 2024), with a median of $6.9861 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG TB CHEW?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LISDEXAMFETAMINE 30 MG CAPSULE, is $3.0366 per EA — about 25% below LISDEXAMFETAMINE 30 MG TB CHEW.

Who manufactures LISDEXAMFETAMINE 30 MG TB CHEW?

LISDEXAMFETAMINE 30 MG TB CHEW (NDC 00480973901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.